Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Increased Numbers of Progenitor Cells in the Apheresis Product of Patients Randomised to Receive Increasing Doses of Stem Cell Factor (r-metHuSCF) Administered in Combination with Chemotherapy and a Standard Dose of Filgrastim (r-metHuG-CSF)

    The optimal regimen for mobilisation of peripheral blood progenitor cells remains to be defined. Many clinical studies have shown enhanced mobilisation when using a combination of a chemotherapeutic agent and ...

    A. Weaver, P. J. Woll, M. Lind, B. Jenkins, C. Gill, T. M. Dexter in Acute Leukemias VII (1998)